title: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
authors.affiliation: Department of Hematology, Erasmus University Medical Center, Cancer Institute Daniel den Hoed, Groene Hilledijk 301, 3075, Rotterdam, The Netherlands, ammatuna@gmail.com.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Ammatuna
authors.forename: Matthias
authors.initials: M
authors.lastname: Eefting
authors.forename: Kirsten
authors.initials: K
authors.lastname: van Lom
authors.forename: François G
authors.initials: FG
authors.lastname: Kavelaars
authors.forename: François F
authors.initials: FF
authors.lastname: Kavelaars
authors.forename: Peter J M
authors.initials: PJ
authors.lastname: Valk
authors.forename: Ivo P
authors.initials: IP
authors.lastname: Touw
mesh_terms: D002352:Carrier Proteins / Q000235:genetics*; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009570:Nitriles; D009687:Nuclear Proteins / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D016184:Receptors, Colony-Stimulating Factor / Q000235:genetics*
chemical_list: C517047:CSF3R protein, human; D002352:Carrier Proteins; D009570:Nitriles; D009687:Nuclear Proteins; D011720:Pyrazoles; D011743:Pyrimidines; D016184:Receptors, Colony-Stimulating Factor; C425066:SETBP1 protein, human; C540383:ruxolitinib; D053612:Janus Kinases